Literature DB >> 17188161

Transforming growth factor-beta: what every pancreatic surgeon should know.

Mark J Truty1, Raul Urrutia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17188161     DOI： 10.1016/j.surg.2006.07.019

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  3 in total

Review 1.  PAR-4 as a possible new target for pancreatic cancer therapy.

Authors:  Asfar S Azmi; Philip A Philip; Syed F Zafar; Fazlul H Sarkar; Ramzi M Mohammad
Journal:  Expert Opin Ther Targets       Date:  2010-06       Impact factor: 6.902

Review 2.  Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer.

Authors:  Siuwah Tang; Jillian Bonaroti; Sebnem Unlu; Xiaoyan Liang; Daolin Tang; Herbert J Zeh; Michael T Lotze
Journal:  Pancreas       Date:  2013-07       Impact factor: 3.327

3.  R2 resection in pancreatic cancer--does it make sense?

Authors:  Jörg Köninger; Moritz N Wente; Beat P Müller-Stich; Francesco F di Mola; Carsten N Gutt; Ulf Hinz; Michael W Müller; Helmut Friess; Markus W Büchler
Journal:  Langenbecks Arch Surg       Date:  2008-02-29       Impact factor: 3.445
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.